公開報告
公開研究報告
由運營明確公開發布到本站的多智能體研究報告。每份都有分析日期與投資組合經理最終評級。僅供研究參考,不構成投資建議,也不執行交易。
來自投資組合經理的五檔最終評級,不是交易員的中間動作。
- 持有
Coca-Cola Company
KONYSEHold current position with tighter $85.00 stop-loss and wait for $92.00+ breakout with momentum confirmation before reassessing exposure.
分析日期2026-09-02
分析語言英語
報告數量1 份
閱讀報告 - 持有
Wells Fargo & Company
WFCNYSEHold current position in Wells Fargo & Company (WFC) pending confirmation at key technical levels.
分析日期2026-09-02
分析語言英語
報告數量1 份
閱讀報告 - 持有
Salesforce, Inc.
CRMNYSEHold current position with disciplined risk management: tighten stop to $268 and take partial profits at $260–$265.
分析日期2026-09-02
分析語言英語
報告數量1 份
閱讀報告 - 減持
System1, Inc. Class A
SSTNYSEReduce existing exposure to minimal or zero position by end of Q3 2026; do not add under any circumstance.
分析日期2026-09-01
分析語言英語
報告數量1 份
閱讀報告 - 持有
Caterpillar Inc.
CATNYSEHold current position; wait for technical breakout above $890.14 and fundamental confirmation of Power & Energy execution before increasing exposure.
分析日期2026-08-31
分析語言英語
報告數量1 份
閱讀報告 - 持有
GE Vernova Inc.
GEVNYSEHold current position in GEV pending decisive technical or fundamental confirmation.
分析日期2026-08-31
分析語言英語
報告數量1 份
閱讀報告 - 持有
Becton, Dickinson and Company
BDXNYSEHold current position with tightened stop at $174.0 and conditional hedge; await resolution of FDA remediation, Phasix data, and Q4 earnings.
分析日期2026-08-21
分析語言英語
報告數量1 份
閱讀報告 - 持有
American States Water Company
AWRNYSEHold current position with a tightened stop-loss at $87.00, awaiting confirmation from Q3 earnings, FCF improvement, and 10Y yield movement.
分析日期2026-08-21
分析語言英語
報告數量1 份
閱讀報告 - 持有
Merck & Co., Inc.
MRKNYSEHold current MRK position pending de-risking catalysts such as FDA filing confirmation, REGAL AML data, or commercial launch clarity.
分析日期2026-08-21
分析語言英語
報告數量1 份
閱讀報告 - 持有
Bank of America Corp
BACNYSEHold current position in Bank of America Corp (BAC), awaiting resolution of India credit quality and AI project viability before adjusting exposure.
分析日期2026-08-19
分析語言英語
報告數量1 份
閱讀報告 - 持有
AbbVie, Inc.
ABBVNYSEHold current position in ABBV pending resolution of the A-327 FDA decision and confirmation of sustained free cash flow generation.
分析日期2026-08-19
分析語言英語
報告數量1 份
閱讀報告 - 持有
Johnson & Johnson
JNJNYSEHold current position, using $266.00 as a dynamic stop-loss and awaiting Q3 earnings and Monarch adoption data for confirmation.
分析日期2026-08-19
分析語言英語
報告數量2 份
閱讀報告 - 持有
Mastercard Incorporated Class A
MANYSEHold current position in MA; maintain neutral sizing while monitoring $559 support and $599 resistance for directional confirmation.
分析日期2026-08-19
分析語言英語
報告數量1 份
閱讀報告 - 持有
Exxonmobil Holdings Corporation
XOMNYSEMaintain current XOM position; no addition or reduction warranted at this time.
分析日期2026-08-19
分析語言英語
報告數量1 份
閱讀報告 - 增持
Visa Inc. Class A
VNYSEOverweight Visa (V) gradually across three tranches, using pullbacks as tactical opportunities while respecting near-term resistance and regulatory risk.
分析日期2026-08-19
分析語言英語
報告數量1 份
閱讀報告 - 增持
JPMorgan Chase & Co.
JPMNYSEGradually increase long exposure to JPM with disciplined entry and dynamic risk controls.
分析日期2026-08-19
分析語言英語
報告數量2 份
閱讀報告 - 增持
Eli Lilly and Company
LLYNYSEOverweight LLY with disciplined, phased accumulation: initiate 25% at $1,280, add 25% at $1,300, and 25% at $1,350 — stop-loss at $1,150.
分析日期2026-08-19
分析語言英語
報告數量1 份
閱讀報告 - 持有
Berkshire Hathaway Inc. Class A
BRK.ANYSEHold current position in BRK.A, using $745,000 and $795,000 as key price-based review triggers.
分析日期2026-08-19
分析語言英語
報告數量1 份
閱讀報告